NATIONAL INSTITUTES OF HEALTH has floated a tender for Neuronext Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional). The project location is USA and the tender is closing on 05 Apr 2024. The tender notice number is PAR-21-224, while the TOT Ref Number is 52846998. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Neuronext Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Deadline : 05 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 52846998

Document Ref. No. : PAR-21-224

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Tender are invited for NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Apr 05, 2024

Posted Date : May 05, 2021

Description: This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Documents

 Tender Notice